Effects of Exercise and Nutritional Interventions During Platinum Chemotherapy on Neuropathy: Examining the Interoceptive Brain System and Inflammation
| ClinicalTrials.gov Identifier |
| NCT05452902 |
| Institution Name |
| University of Maryland, Baltimore |
| Full Institution Address |
|
655 W Lombard St, Baltimore, MD 21201 Baltimor Maryland 21201 United States |
| Institution Phone |
| (410) 706-7391 |
| Institution Website |
| http://www.iankleckner.com/ |
| Additional Institutions |
|
| Principal Investigator |
| Dr. Ian Kleckner |
| Principal Investigator Phone |
| (410) 706-5981 |
| Principal Investigator Email |
| ian.kleckner@umaryland.edu |
| Study Coordinator |
| Javier Rosales |
| Study Coordinator Phone |
| (410) 706-7391 |
| Study Coordinator Email |
| jrosales@umaryland.edu |
| Additional Study Coordinators |
|
Amelia Wagenknecht (202)503 4411 awagenknecht@umaryland.edu |
| Study Overview |
| Chemotherapy-induced peripheral neuropathy (CIPN) is a highly prevalent and severe side-effect of platinum-based chemotherapy, often used to treat gastrointestinal cancers. There are very limited treatments for CIPN. This is a phase II randomized controlled trial to test the preliminary efficacy of exercise vs. nutrition education on CIPN. |
| Enrollment Information |
| 4 |
| Study Start Date |
| 20221025 |
| Study End Date |
| 20251201 |
| Study Purpose |
|
| Inclusion Criteria |
|
| Exclusion Criteria |
|
| Required Tests Prior to Study |
|
| Potential Side Effects |
|
| Financial Assistance Available |
| Yes |